TORONTO, October 2nd, 2019 – JDRF welcomes the Conservative announcement yesterday committing to legislation making it easier for Cana...Read More
JDRF Announces New Partnership with the European Foundation for the Study of Diabetes and Eli Lilly and Company to Fund Novel Diabetes Research
JDRF, the leading research and advocacy organization funding type 1 diabetes (T1D) research announced today a new research partnership with the European Foundation for the Study of Diabetes (EFSD) and Eli Lilly and Company to establish a new research funding program to accelerate type 1 diabetes dis...
Scientists at the University of British Columbia and BetaLogics, part of Janssen Research & Development, LLC have shown for the first time that Type 2 diabetes can be effectively treated with a combination of specially-cultured stem cells and conventional diabetes drugs.
JDRF-funded program at the Centre for Global eHealth Innovation establishes open communication standards to enhance diabetes management and accelerate artificial pancreas research
JDRF in the Globe and Mail, November 25, 2014: For kids, research and new treatment options bring less discomfort and better outcomes
JDRF showcases advancements in CGM technology in making monitoring of glucose levels better and the new experimental encapsulated cell replacement therapy.
First Ever Person with Type 1 Diabetes Receives Experimental Encapsulated Human Stem Cell-Derived Beta Cell Replacement Therapy
Dave Prowten and JDRF Youth Ambassador discuss Kids for a Cure Awareness Day with CTV Canada AM on Nov. 14
EFFECTIVE DIABETES MANAGEMENT: Type 1 diabetes (T1D) strikes children and adults suddenly, and lasts a lifetime.
JDRF showcases advancements in T1D pregnancy care; highlighting JDRF CCTN and the CONCEPTT Trial, and exploring the challenges of managing T1D through pregnancy.
40 Kids and Country Superstar George Canyon Step up to Cure Type 1 Diabetes (T1D) JDRF Ambassadors head to Parliament Hill to discuss the importance of funding research
Lilly Canada provided JDRF with $220,000 in 2013-2014 in support of the creation of a national clinical training program to enable young investigators to further engage in medical research associated with type 1 diabetes.